Yisheng Biopharma Co., Ltd., a biopharmaceutical company focusing on research, development, manufacturing, sales and mar...
Eisai Co., Ltd. has announced that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administ...
Atox Bio, a clinical stage biotechnology company developing novel therapies for critically ill patients has announced th...
Immutep Limited has announced that it has entered into a clinical trial collaboration and supply agreement with Merck KG...
David T. Novotny was recently named Chief Strategy Officer (CSO) of Proxima Clinical Research, Inc., a leader in clinica...
Excerpts from the interview In the context of emerging markets in APAC, what are some of the opportunities and challeng...
Innovent Biologics, a world-class China-based biopharmaceutical company that develops and commercializes high quality dr...
The Center for Information and Study on Clinical Research Participation (CISCRP), a Boston-based nonprofit organization,...
Three groundbreaking papers published in New England Journal of Medicine, led by a team of Monash University researchers...
Medtronic has initiated a new clinical study in patients implanted with its Resolute Onyx drug-eluting stent (DES) durin...
Oryzon Genomics, a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseas...
TB Alliance, a not-for-profit organization dedicated to finding faster-acting and affordable drug regimens to fight...
Singapore - An in-depth study on the regulation of adenosine-to-inosine (A-to-I) RNA editing by researchers from the Can...
Tolero Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for hematologi...
Lion TCR Pte. Ltd., a Singapore-based Biotech company has received approval from Health Sciences Authority (HSA), Singap...
FSD Pharma announced the launch of a clinical research collaborative program in Israel, via its strategic R&D p...
Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) has announced that results of the global Phase 3 MAVORIC study (Mogamulizumab...
Ascletis announced that the Ganovo phase III clinical study won the top clinical research award at the 15th National Con...
